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Poster Presentation 1
THE "COMBINED" 192 IGG SAPORIN LESION APPROACH AS AN
ANIMAL MODEL OF ALZHEIMER'S DISEASE

Katharine Trickle and Wayne Dornan*, Department of Psychology, IWU
While significant progress has been made toward an understanding of the
etiology of AD , presently no reliable animal model exists that mimics the
profound pathological and behavioral changes that characterize the disease.
Accumulating evidence from a large number of studies conducted in the rat
reveal that disruption of the functional integrity of the cholinergic basal
forebrain projection to the hippocampus and cortex using cholinergic
antagonists or specific lesions of the medial septal area (MSA) and nucleus
basalis magnocellularis (NBM) induce marked impairments on a variety of
behavioral tasks, particularly those that involve spatial learning (e.g. Morris
water maze, and radial arm maze). Recently, 192 IgG saporin has been has
been reported to be a selective cholinergic neurotoxin. Unilateral injections of
192 IgG saporin into the lateral ventricles induce a 80-90% reduction of
acetylcholine levels in the cortex and hippocampus. Although several studies
have reported an impairment of spatial learning following intraventricular
injections of saporin, all have noted that the effects observed may be due to
loss of cerebellar Purkinje cells damaged following intraventricular (i.c.v. )
injections of 192 IgG saporin. Indeed, in a recent article published by Walsh,
Kelly, Dougherty, Stackman, Wiley, and Kutscher in the journal Brain
Research (702: 233-245, 1995) the authors conclude that although 192 IgG
saporin is a highly selective cholinergic toxin, the secondary effects induced
by i.c.v. injections of 192 IgG saporin " makes the i.c.v. model of 192 IgG
saporin problematic for studying the role of the cholinergic basal forebrain
(CBF) in normative behavior and in disease states ". The authors further
suggest that site-specific injections of 192 IgG saporin would provide a viable
approach to model Alzheimer's disease. In order to circumvent the problem of
cerebellar Purkinje cell damage following i.c.v. injection of 192 IgG saporin,
while at the same time producing a cholinergic lesion that essentially
destroys 80 -90 % of the cholinergic input to the hippocampus and cortex in
the rat, we have employed a "combined lesion" technique where animals
receive three injections of 192 IgG saporin into the medial septal area, and
two (bilateral) injections into the nucleus basalis magnocellularis. In a series
of studies that will be presented at this conference, the effects of this
"combined " lesion approach on spatial learning in the rat will be reported.
We hope that the "combined lesion model " using 192 IgG-saporin by
circumventing the inherent problems associated with i.c.v. injections of
saporin may provide an avenue to test novel therapeutic drugs to be used as a
palliative treatment for Alzheimer's disease.

